Jayastu Senapati

Assistant professor

The University of Texas MD Anderson Cancer Center

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Jayastu Senapati is an Assistant Professor at The University of Texas MD Anderson Cancer Center in the United States. His research focuses on acute myeloid leukemia and acute lymphoblastic leukemia, examining outcomes and treatment strategies in various patient populations. Recent works include investigations into the prognostic implications of genetic mutations and the effectiveness of innovative therapeutic combinations in hematological malignancies.

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

View details

Courtney D. DiNardo

UNITED STATES

View details

Musa Yilmaz

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Naval G. Daver

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Jayastu Senapati

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Contemporary outcomes of octa‐nonagenarians with newly diagnosed acute myeloid leukemia

Outcomes of patients with newly diagnosed acute myeloid leukemia with FLT3‐tyrosine kinase domain mutations: Prognostic implications of NPM1 co‐mutation

Outcomes and patterns of relapse with ponatinib-based therapy in patients with chronic myeloid leukemia in myeloid blast phase

Mini-Hyper-CVD plus Venetoclax and Navitoclax for Relapsed/Refractory Acute Lymphoblastic Leukemia

Advances in Acute Lymphoblastic Leukemia Review Series

Characteristics and outcomes of newly diagnosed acute myeloid Leukemia with KMT2A rearrangements

Azacitidine, Venetoclax, and Magrolimab in Newly Diagnosed and Relapsed Refractory Acute Myeloid Leukemia: Phase Ib/II Study and Correlative Analysis

Barriers to allogeneic stem cell transplantation in responding patients with TP53-mutated acute myeloid leukemia

Frontline immunotherapeutic combination strategies in adult B-cell acute lymphoblastic leukemia: reducing chemotherapy intensity and toxicity and harnessing efficacy

Clinico‐Genomic Interrogation of Secondary‐Type Acute Myeloid Leukemia: Response and Outcomes to Contemporary Therapies

Collaborators (9)

Fadi Haddad

Koji Sasaki

Nitin Jain

PRITHVIRAJ BOSE

Patrick Reville

Elias J. Jabbour

Courtney D. DiNardo

Musa Yilmaz

Naval G. Daver

Make your next move.